-
1
-
-
0031923741
-
Comparison of markers of bone formation and resorption in prostate cancer patients to predict bone metastasis
-
Akimoto S., Furuya Y., Akakura K. & Ito H. (1998) Comparison of markers of bone formation and resorption in prostate cancer patients to predict bone metastasis. Endocrine Journal 45, 97–104.
-
(1998)
Endocrine Journal
, vol.45
, pp. 97-104
-
-
Akimoto, S.1
Furuya, Y.2
Akakura, K.3
Ito, H.4
-
2
-
-
0026229321
-
Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma
-
Amico S., Liehn J.C., Desoize B., Larbre H., Deltour G. & Valeyre J. (1991) Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma. Clinical Nuclear Medicine 16, 643–648.
-
(1991)
Clinical Nuclear Medicine
, vol.16
, pp. 643-648
-
-
Amico, S.1
Liehn, J.C.2
Desoize, B.3
Larbre, H.4
Deltour, G.5
Valeyre, J.6
-
3
-
-
19944432878
-
Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors
-
Brown J.E., Cook R.J., Major P., Lipton A., Saad F., Smith M., Lee K.A., Zheng M., Hei Y.J. & Coleman R.E. (2005) Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. Journal of the National Cancer Institute 97, 59–69.
-
(2005)
Journal of the National Cancer Institute
, vol.97
, pp. 59-69
-
-
Brown, J.E.1
Cook, R.J.2
Major, P.3
Lipton, A.4
Saad, F.5
Smith, M.6
Lee, K.A.7
Zheng, M.8
Hei, Y.J.9
Coleman, R.E.10
-
4
-
-
0031405795
-
Biochemical markers of bone metabolism: an overview
-
Christenson R.H. (1997) Biochemical markers of bone metabolism: an overview. Clinical Biochemistry 30, 573–593.
-
(1997)
Clinical Biochemistry
, vol.30
, pp. 573-593
-
-
Christenson, R.H.1
-
5
-
-
24644479228
-
Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid
-
Coleman R.E., Major P., Lipton A., Brown J.E., Lee K.A., Smith M., Saad F., Zheng M., Hei Y.J., Seaman J. & Cook R. (2005) Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid. Journal of Clinical Oncology 23, 4925–4935.
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 4925-4935
-
-
Coleman, R.E.1
Major, P.2
Lipton, A.3
Brown, J.E.4
Lee, K.A.5
Smith, M.6
Saad, F.7
Zheng, M.8
Hei, Y.J.9
Seaman, J.10
Cook, R.11
-
6
-
-
6344284449
-
Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients
-
Ebert W., Muley T., Herb K.P. & Schmidt‐Gayk H. (2004) Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients. Anticancer Research 24, 3193–3201.
-
(2004)
Anticancer Research
, vol.24
, pp. 3193-3201
-
-
Ebert, W.1
Muley, T.2
Herb, K.P.3
Schmidt‐Gayk, H.4
-
7
-
-
13644265713
-
The role of whole‐body bone scanning and clinical factors in detecting bone metastases in patients with non‐small cell lung cancer
-
Erturan S., Yaman M., Aydin G., Uzel I., Musellim B. & Kaynak K. (2005) The role of whole‐body bone scanning and clinical factors in detecting bone metastases in patients with non‐small cell lung cancer. Chest 127, 449–454.
-
(2005)
Chest
, vol.127
, pp. 449-454
-
-
Erturan, S.1
Yaman, M.2
Aydin, G.3
Uzel, I.4
Musellim, B.5
Kaynak, K.6
-
8
-
-
0034660097
-
Markers of bone turnover in bone metastases
-
Fontana A. & Delmas P.D. (2000) Markers of bone turnover in bone metastases. Cancer 88 (Suppl. 12), 2952–2960.
-
(2000)
Cancer
, vol.88
, Issue.Suppl. 12
, pp. 2952-2960
-
-
Fontana, A.1
Delmas, P.D.2
-
9
-
-
21344432098
-
Skeletal complications of prostate cancer: pathophysiology and therapeutic potential of bisphosphonates
-
Green J.R. (2005) Skeletal complications of prostate cancer: pathophysiology and therapeutic potential of bisphosphonates. Acta Oncologica 44, 282–292.
-
(2005)
Acta Oncologica
, vol.44
, pp. 282-292
-
-
Green, J.R.1
-
10
-
-
0642342669
-
American society of clinical oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer
-
Hillner B.E., Ingle J.N., Chlebowski R.T., Gralow J., Yee G.C., Janjan N.A., Cauley J.A., Blumenstein B.A., Albain K.S., Lipton A. & Brown S. (2003) American society of clinical oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. Journal of Clinical Oncology 21, 4042–4057.
-
(2003)
Journal of Clinical Oncology
, vol.21
, pp. 4042-4057
-
-
Hillner, B.E.1
Ingle, J.N.2
Chlebowski, R.T.3
Gralow, J.4
Yee, G.C.5
Janjan, N.A.6
Cauley, J.A.7
Blumenstein, B.A.8
Albain, K.S.9
Lipton, A.10
Brown, S.11
-
11
-
-
4043064387
-
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications
-
Jung K., Lein M., Von Stephan C.H.K., Semjonow A., Sinha P., Loening S.A. & Schnorr D. (2004) Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. International Journal of Cancer 111, 783–791.
-
(2004)
International Journal of Cancer
, vol.111
, pp. 783-791
-
-
Jung, K.1
Lein, M.2
Von Stephan, C.H.K.3
Semjonow, A.4
Sinha, P.5
Loening, S.A.6
Schnorr, D.7
-
12
-
-
1342306706
-
Determination and biological relevance of serum cross‐linked type I collagen N‐telopeptide and bone‐specific alkaline phosphatase in breast metastatic cancer
-
Kanakis I., Nikolaou M., Pectasides D., Kiamouris C. & Karamanos N.K. (2004) Determination and biological relevance of serum cross‐linked type I collagen N‐telopeptide and bone‐specific alkaline phosphatase in breast metastatic cancer. Journal of Pharmaceutical and Biomedical Analysis, 34, 827–832.
-
(2004)
Journal of Pharmaceutical and Biomedical Analysis
, vol.34
, pp. 827-832
-
-
Kanakis, I.1
Nikolaou, M.2
Pectasides, D.3
Kiamouris, C.4
Karamanos, N.K.5
-
13
-
-
0037301970
-
Bisphosphonates and metastatic breast carcinoma
-
Lipton A. (2003) Bisphosphonates and metastatic breast carcinoma. Cancer 97 (Suppl. 3), 848–853.
-
(2003)
Cancer
, vol.97
, Issue.Suppl. 3
, pp. 848-853
-
-
Lipton, A.1
-
14
-
-
4644239072
-
Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention
-
Lipton A. (2004) Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention. The Journal of Supportive Oncology 2, 205–213.
-
(2004)
The Journal of Supportive Oncology
, vol.2
, pp. 205-213
-
-
Lipton, A.1
-
15
-
-
18744424072
-
The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate
-
Lipton A., Small E., Saad F., Gleason D., Gordon D., Smith M., Rosen L., Kowalski M.O., Reitsma D. & Seaman J. (2002) The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate. Cancer Investigation 20 (Suppl. 2), pp. 45–54.
-
(2002)
Cancer Investigation
, vol.20
, Issue.Suppl. 2
, pp. 45-54
-
-
Lipton, A.1
Small, E.2
Saad, F.3
Gleason, D.4
Gordon, D.5
Smith, M.6
Rosen, L.7
Kowalski, M.O.8
Reitsma, D.9
Seaman, J.10
-
16
-
-
0027208712
-
Multiple forms of human serum alkaline phosphatase: detection and quantitation
-
Price C.P. (1993) Multiple forms of human serum alkaline phosphatase: detection and quantitation. Annals of Clinical Biochemistry 30 (Part 4), 355–372.
-
(1993)
Annals of Clinical Biochemistry
, vol.30
, Issue.Part 4
, pp. 355-372
-
-
Price, C.P.1
-
17
-
-
2942518111
-
Long‐term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone‐refractory prostate cancer
-
Saad F., Gleason D.M., Murray R., Tchekmedyian S., Venner P., Lacombe L., Chin J.L., Vinholes J.J., Goas J.A. & Zheng M. (2004) Long‐term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone‐refractory prostate cancer. Journal of the National Cancer Institute 96, 879–882.
-
(2004)
Journal of the National Cancer Institute
, vol.96
, pp. 879-882
-
-
Saad, F.1
Gleason, D.M.2
Murray, R.3
Tchekmedyian, S.4
Venner, P.5
Lacombe, L.6
Chin, J.L.7
Vinholes, J.J.8
Goas, J.A.9
Zheng, M.10
-
18
-
-
0031768771
-
Efficacy of skeletal alkaline phosphatase and prostate‐specific antigen in the diagnosis of bone metastasis in cancer of the prostate
-
Wolff J.M., Ittel T., Borchers H., Brauers A. & Jakse G. (1998) Efficacy of skeletal alkaline phosphatase and prostate‐specific antigen in the diagnosis of bone metastasis in cancer of the prostate. Urologia Internationalis 61, 12–16.
-
(1998)
Urologia Internationalis
, vol.61
, pp. 12-16
-
-
Wolff, J.M.1
Ittel, T.2
Borchers, H.3
Brauers, A.4
Jakse, G.5
|